Replies to post #45342 on RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

I was under the impression that they have tested the new OSA nano formulations to be able to meet their requirements to move forward into human trials. Although, maybe doing pre-clinical work currently?

With KRM-II-81, I think they have done many preclinicals and finishing up with NIH in preps for human clinicals. I am sure drug delivery efficiency plays a role in all trials for all drugs, but with the OSA drug nano technology can overcome the extended release requirements with low dosage.